Huan Shu
Ms. Shu specializes in complex securities valuation for financial reporting and tax purposes. She has extensive valuation expertise in complex financial instruments, including 409A valuation,…
Why VRC for Portfolio Valuation?
Learn why eminent private fund managers and their boards rely on our team.
PJ Patel and Dwight Grant to Co-chair Inaugural ASA Complex Securities Conference
The event features presentations from nationally recognized speakers who are leaders in the securities industry and will cover a range of topics, including SPACs, contingent consideration, and volatility.
Shri Shetty
Ms. Shetty specializes in valuation of share-based compensation, options, derivatives, and complex securities. Prior to VRC, Ms. Shetty was an intern at Merrill Lynch where…
Leon Li
Mr. Li specializes in valuing complex securities including options, warrants, fixed income and credit derivatives, structured products and other derivatives. Prior to joining VRC, Mr.…
Dwight Grant
In his role as Senior Advisor to VRC, Mr. Grant advises VRC and clients on the valuations of financial instruments, derivatives, and complex securities related…
Pharmaceuticals
In order to comply with Accounting Standards Codification 815 (ASC 815), an early stage pharmaceutical company asked VRC to analyze the entire convertible callable note and determine the fair market value of each of the embedded derivatives.